SKI Market

Indian Indices

Sensex

85,408.70 -116.14
( -0.14%)

Global Indices

Nasdaq

48,460.34 76.65
(0.16%)

Dow Jones

6,930.02 30.53
(0.44%)

Hang Seng

50,375.92 -36.95
(-0.07%)

Nikkei 225

9,896.28 30.31
(0.31%)

Forex

USD-INR

89.61 0.03
(0.04%)

EUR-INR

105.18 0.31
(0.29%)

GBP-INR

120.34 0.55
(0.45%)

JPY-INR

0.57 0.00
(0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

539524

INE600L01024

139.7171745

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LALPATHLAB

44.7

23635.58

EPS(TTM)

Face Value()

Div & Yield %

31.56

0.85

Back

sylph industries ltd

Dr Lal Pathlabs consolidated net profit rises 16.41% in the September 2025 quarter

Oct 31,2025

Net profit of Dr Lal Pathlabs rose 16.41% to Rs 150.40 crore in the quarter ended September 2025 as against Rs 129.20 crore during the previous quarter ended September 2024. Sales rose 10.66% to Rs 730.60 crore in the quarter ended September 2025 as against Rs 660.20 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	730.60	660.20	11
OPM %	30.67	30.67	-
PBDT	244.10	218.40	12
PBT	203.60	183.10	11
NP	150.40	129.20	16

85,408.70 -116.14 ( -0.14%)

48,460.34 76.65 (0.16%)

6,930.02 30.53 (0.44%)

50,375.92 -36.95 (-0.07%)

9,896.28 30.31 (0.31%)

89.61 0.03 (0.04%)

105.18 0.31 (0.29%)

120.34 0.55 (0.45%)

0.57 0.00 (0.36%)